BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
40 results:

  • 1. Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
    He T; Cheng C; Qiao Y; Cho H; Young E; Mannan R; Mahapatra S; Miner SJ; Zheng Y; Kim N; Zeng VZ; Wisniewski JP; Hou S; Jackson B; Cao X; Su F; Wang R; Chang Y; Kuila B; Mukherjee S; Dukare S; Aithal KB; D S S; Abbineni C; Vaishampayan U; Lyssiotis CA; Parolia A; Xiao L; Chinnaiyan AM
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2322563121. PubMed ID: 38557192
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
    Wang Z; Ye J; Hu J; Zhang N; Yuan Y
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment and validation of preclinical models of smarca4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
    Wong NKY; Llaurado Fernandez M; Kommoss FKF; Praveen Kumar P; Kim H; Liu J; Zhang G; Coatham M; Lin YY; Haegert AM; Volik S; Le Bihan S; Collins CC; Fu Y; Postovit LM; von Deimling A; Wu R; Xue H; Wang Y; Köbel M; Carey MS; Lee CH
    Gynecol Oncol; 2023 Sep; 176():162-172. PubMed ID: 37556934
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
    Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
    Elife; 2023 Mar; 12():. PubMed ID: 36883553
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
    Shishodia S; Nuñez R; Strohmier BP; Bursch KL; Goetz CJ; Olp MD; Jensen DR; Fenske TG; Ordonez-Rubiano SC; Blau ME; Roach MK; Peterson FC; Volkman BF; Dykhuizen EC; Smith BC
    J Med Chem; 2022 Oct; 65(20):13714-13735. PubMed ID: 36227159
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. OTUD6A promotes prostate tumorigenesis via deubiquitinating brg1 and AR.
    Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
    Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
    Xiao L; Parolia A; Qiao Y; Bawa P; Eyunni S; Mannan R; Carson SE; Chang Y; Wang X; Zhang Y; Vo JN; Kregel S; Simko SA; Delekta AD; Jaber M; Zheng H; Apel IJ; McMurry L; Su F; Wang R; Zelenka-Wang S; Sasmal S; Khare L; Mukherjee S; Abbineni C; Aithal K; Bhakta MS; Ghurye J; Cao X; Navone NM; Nesvizhskii AI; Mehra R; Vaishampayan U; Blanchette M; Wang Y; Samajdar S; Ramachandra M; Chinnaiyan AM
    Nature; 2022 Jan; 601(7893):434-439. PubMed ID: 34937944
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BAF57 Is a Potential Determinant of Colorectal cancer Malignancy.
    Suzumura H; Tsuruta M; Okabayashi K; Shigeta K; Seishima R; Ishida T; Shimada T; Asada Y; Koishikawa K; Akimoto S; Itano O; Hasegawa H; Kitagawa Y
    Anticancer Res; 2021 Nov; 41(11):5445-5452. PubMed ID: 34732413
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation-Mass Spectrometry Assays.
    Fu Z; Rais Y; Bismar TA; Hyndman ME; Le XC; Drabovich AP
    Mol Cell Proteomics; 2021; 20():100075. PubMed ID: 33771697
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. brg1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
    Giles KA; Gould CM; Achinger-Kawecka J; Page SG; Kafer GR; Rogers S; Luu PL; Cesare AJ; Clark SJ; Taberlay PC
    Clin Epigenetics; 2021 Feb; 13(1):37. PubMed ID: 33596994
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MUC1-C Activates the BAF (mSWI/SNF) Complex in prostate cancer Stem Cells.
    Hagiwara M; Yasumizu Y; Yamashita N; Rajabi H; Fushimi A; Long MD; Li W; Bhattacharya A; Ahmad R; Oya M; Liu S; Kufe D
    Cancer Res; 2021 Feb; 81(4):1111-1122. PubMed ID: 33323379
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
    Cyrta J; Augspach A; De Filippo MR; Prandi D; Thienger P; Benelli M; Cooley V; Bareja R; Wilkes D; Chae SS; Cavaliere P; Dephoure N; Uldry AC; Lagache SB; Roma L; Cohen S; Jaquet M; Brandt LP; Alshalalfa M; Puca L; Sboner A; Feng F; Wang S; Beltran H; Lotan T; Spahn M; Kruithof-de Julio M; Chen Y; Ballman KV; Demichelis F; Piscuoglio S; Rubin MA
    Nat Commun; 2020 Nov; 11(1):5549. PubMed ID: 33144576
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting the BAF complex in advanced prostate cancer.
    Hartley A; Leung HY; Ahmad I
    Expert Opin Drug Discov; 2021 Feb; 16(2):173-181. PubMed ID: 32936685
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. HMGB1 Promotes prostate cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
    Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
    Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
    [No Abstract]    [Full Text] [Related]  

  • 15. The chromatin remodeling protein brg1 links ELOVL3 trans-activation to prostate cancer metastasis.
    Yang Y; Liu L; Li M; Cheng X; Fang M; Zeng Q; Xu Y
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):834-845. PubMed ID: 31154107
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chromatin remodeling ATPase brg1 and PTEN are synthetic lethal in prostate cancer.
    Ding Y; Li N; Dong B; Guo W; Wei H; Chen Q; Yuan H; Han Y; Chang H; Kan S; Wang X; Pan Q; Wu P; Peng C; Qiu T; Li Q; Gao D; Xue W; Qin J
    J Clin Invest; 2019 Feb; 129(2):759-773. PubMed ID: 30496141
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. BAF53A regulates androgen receptor-mediated gene expression and proliferation in LNCaP cells.
    Jin ML; Kim YW; Jeong KW
    Biochem Biophys Res Commun; 2018 Oct; 505(2):618-623. PubMed ID: 30278885
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
    Alpsoy A; Dykhuizen EC
    J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.